News and commentary about white-collar crime, enforcement, and compliance
Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
I have a great deal of respect for Martin Kenney’s efforts in taking fraudsters to task and recovering funds on behalf of their victims. However, I found his recent post for the FCPA Blog about the so-called Paradise Papers to be deeply misguided.
South Korea Thursday fined Swiss pharma Novartis $48.3 million for paying doctors kickbacks to prescribe the company’s drugs.
A former saleswoman for medical device maker Acclarent was awarded $3.5 million as her share of an $18 million settlement of a whistleblower suit alleging false marketing claims.
We conducted research on 30 corporate corruption FCPA cases resulting from SEC investigations and sanctions over the last 15 years. The aim of this research was to uncover what negative features these organizations have in their cultures.
The government of Iraq filed a civil suit in late June in federal district court in New York City against two individuals and about 50 companies and some of their related firms for bribery that allegedly occurred under the United Nations oil-for-food program. Referring to the U.N. program as “the largest financial fraud in human […]
Novartis AG said in a securities filing last week that Korean prosecutors launched a criminal investigation into allegations that “Novartis Korea utilized medical journals to provide inappropriate economic benefits to healthcare professionals.”
Foreign companies can’t be blamed for wondering if they’re being singled out under the Foreign Corrupt Practices Act. The names in the FCPA-related headlines alone are enough to cause high anxiety. ABB, Siemens, BAE, DaimlerChrysler, AstraZeneca and many more. But are U.S. prosecutors really focusing too much attention on U.K., European and other foreign companies […]
An official in central China’s Hunan province has been placed under graft probe after an online photo showed him wearing a Louis Vuitton belt.
In-house lawyers, we said yesterday, are now caught between their duty as advocates on the one hand, and the modern concept of ethics and compliance on the other hand. Talk about a headache.
In a post here we described our edits to Wikipedia’s article on the Foreign Corrupt Practices Act (here). Wiki’s old article said a bank owner (pictured far left) whose brother was the minister of finance (far right) would be a foreign official for the FCPA. That’s wrong, we said, because although consanguinity might be important, […]